Multidrug-resistant and biofilm-forming pathogens have become a global health challenge, contributing to persistent and hard-to-treat infections.
The objective of this study was to characterize an active metabolite produced by a novel halo-thermophilic Streptomyces sp.
CBN-1 that exhibits potent antibacterial and antibiofilm activities using a combined in-silico and experimental approach.
